Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Smart opioid dispenser and app for patients having a one-level lumbar discectomy or laminectomy

Official title: Use of a Novel Device to Dispense Postoperative Opioids in Patients Undergoing Microdiscectomy/Laminectomy: A Pilot Study

Run by Hospital for Special Surgery, New York · NCT06358040 · Data updated 2026-11-12

This test tries a locked opioid-dispensing device plus a smartphone app to help adults having a one-level lumbar discectomy or laminectomy who are opioid-naive or occasional users take oxycodone more safely after discharge.

More Opioid Use trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorHospital for Special Surgery, New York
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedOctober 2026
Main results expectedOctober 2026
Study endsDecember 2026
Registry record updatedDecember 8, 2025
Trial IDNCT06358040 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older who are opioid-naive or intermittent users within the past three months, scheduled for a primary elective one-level posterior lumbar laminectomy or discectomy with planned same-day or 23-hour discharge, who have a smartphone and can use the dispensing device are ideal candidates.

Probably not a fit

Patients who are opioid-tolerant, unable to use a smartphone or the dispensing device, pregnant, allergic to oxycodone, planned for inpatient admission or discharge to a facility, or who require a different opioid are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares a locked opioid-dispensing device paired with a smartphone app to the standard opioid pill bottle for adults undergoing primary elective one-level posterior lumbar laminectomy or discectomy. Eligible participants who are opioid-naive or intermittent users and planned for same-day or 23-hour discharge will receive oxycodone dispensed either by the device with app-based instructions and telehealth follow-up or by the usual pill bottle. Investigators will monitor opioid consumption, adherence to dosing, side effects, and safe storage and disposal behaviors after surgery. The trial aims to determine whether the device and app reduce unsafe use, leftover pills, and opioid-related adverse events in the postoperative period.

Why it matters

Potential benefit: If successful, this approach could reduce unsafe opioid use and leftover pills after spinal surgery while improving adherence to prescribed dosing and patient safety.

How similar studies have gone: Previous smaller studies of locked dispensers and app-based opioid education in other surgical populations have shown reduced leftover pills and improved adherence, but applying this approach specifically after lumbar discectomy/laminectomy is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* opioid-naive patients or intermittent opioid users within 3 months of scheduled surgery
* At least 18 years old
* presenting for primary elective one-level lumbar laminectomy and/or discectomy via posterior approach with participating surgeon
* planned discharge on day of surgery/23 hour admission
* planned discharge to home

Exclusion Criteria:

* patients with opioid-tolerance
* patients without a smart-phone or without the ability to perform Telehealth visits
* patients unable to utilize the medication dispensing device
* patients presenting for other surgeries/surgeries with combined anterior/lateral approaches
* patient refusal
* allergy or intolerance to opioids
* planned admission after surgery
* planned discharge disposition to nursing facility or skilled rehabilitation
* planned use of or preference for opioid other than oxycodone
* patients who are pregnant

Where it's running

  • Hospital for Special Surgery
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Vladimir Kramskiy, MD — Hospital for Special Surgery, New York
  • Study coordinator: William Chan, MEng
  • Email: chanw@hss.edu
  • Phone: 917-260-4788

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.